BCLS Fund III Investments LP 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-29 4:45 pm Purchase | 2024-07-18 | 13G | Cidara Therapeutics, Inc. CDTX | BCLS Fund III Investments LP | 703,080 9.990% | 703,080 (New Position) | Filing |